22636-79-9

Basic information

• Product Name: 3-(DIMETHYLAMINO)PROPANOHYDRAZIDE
• Synonyms: N,N-Dimethyl-b-aminopropionic hydrazide;N-Amino-3-(dimethylamino)propanamide
• CAS NO: 22636-79-9
• Molecular Formula: C5H13N3O
• Molecular Weight: 131.17886
• Mol File: 22636-79-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 273.1°Cat760mmHg
• Flash Point: 119°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 0.00583mmHg at 25°C
• Refractive Index: 1.476
• PKA: 13.32±0.18(Predicted)
• CAS DataBase Reference: 3-(DIMETHYLAMINO)PROPANOHYDRAZIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(DIMETHYLAMINO)PROPANOHYDRAZIDE(22636-79-9)
• EPA Substance Registry System: 3-(DIMETHYLAMINO)PROPANOHYDRAZIDE(22636-79-9)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 22636-79-9(Hazardous Substances Data)

Usage

General Description

3-(dimethylamino)propanohydrazide is a chemical compound with the molecular formula C5H13N3O. It is a hydrazide derivative with a dimethylamino group attached to the third carbon of the propanoic acid chain. 3-(DIMETHYLAMINO)PROPANOHYDRAZIDE is commonly used as a chemical intermediate in the production of pharmaceuticals, dyes, and agrochemicals. It is also used as a reagent in organic synthesis and as a precursor in the manufacture of various compounds. Additionally, 3-(dimethylamino)propanohydrazide has potential applications in the development of new materials and in chemical research.

InChI:InChI=1/C5H13N3O/c1-8(2)4-3-5(9)7-6/h3-4,6H2,1-2H3,(H,7,9)

Upstream product

• 20120-21-2 ethyl 3-(N,N-dimethylamino)propionate 
• 3853-06-3 methyl 3-(dimethylamino)propionate 

Relevant articles and documents

A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1

Human 15-lipoxygenase-1 (15-LOX-1) is a mammalian lipoxygenase which plays an important regulatory role in several CNS and inflammatory lung diseases. To further explore the role of this enzyme in drug discovery, novel potent inhibitors with favorable phy

Methods for treating an inflammatory condition or inhibiting JNK

This invention is generally directed to Indazole Derivatives having the following structure: 1 or pharmaceutically acceptable salt thereof, wherein R1, R2 and A are as defined herein. Such compounds have utility in the treatment of a wide range of diseases and disorders that are responsive to JNK inhibition, such as an inflammatory disease or disorder. Thus, methods of treating such diseases and disorders are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

SYNTHESIS OF ALIPHATIC AMINO-ACID HYDRAZIDES AS POTENTIAL

-